vs

Side-by-side financial comparison of AVADEL PHARMACEUTICALS PLC (AVDL) and GETTY REALTY CORP (GTY). Click either name above to swap in a different company.

AVADEL PHARMACEUTICALS PLC is the larger business by last-quarter revenue ($77.5M vs $57.8M, roughly 1.3× GETTY REALTY CORP). GETTY REALTY CORP runs the higher net margin — 46.0% vs 0.0%, a 46.0% gap on every dollar of revenue. On growth, AVADEL PHARMACEUTICALS PLC posted the faster year-over-year revenue change (54.9% vs 10.5%). Over the past eight quarters, AVADEL PHARMACEUTICALS PLC's revenue compounded faster (99.6% CAGR vs 7.6%).

Avadel Pharmaceuticals, is an Irish specialty pharmaceutical company that focuses on sleep disorder medicines. Avadel markets products in the hospital and primary care spaces. The company is headquartered in Dublin, Ireland with operations in St. Louis, Missouri and Lyon, France.

Getty Realty Corp is a publicly traded real estate investment trust (REIT) headquartered in the United States. It owns, leases, and manages a diversified portfolio of commercial real estate assets, primarily consisting of convenience stores, fuel stations, and adjacent retail locations across U.S. states, serving tenants across retail and energy sectors.

AVDL vs GTY — Head-to-Head

Bigger by revenue
AVDL
AVDL
1.3× larger
AVDL
$77.5M
$57.8M
GTY
Growing faster (revenue YoY)
AVDL
AVDL
+44.3% gap
AVDL
54.9%
10.5%
GTY
Higher net margin
GTY
GTY
46.0% more per $
GTY
46.0%
0.0%
AVDL
Faster 2-yr revenue CAGR
AVDL
AVDL
Annualised
AVDL
99.6%
7.6%
GTY

Income Statement — Q3 FY2025 vs Q1 FY2026

Metric
AVDL
AVDL
GTY
GTY
Revenue
$77.5M
$57.8M
Net Profit
$20.0K
$26.6M
Gross Margin
Operating Margin
2.5%
66.1%
Net Margin
0.0%
46.0%
Revenue YoY
54.9%
10.5%
Net Profit YoY
100.8%
80.1%
EPS (diluted)
$0.00
$0.43

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AVDL
AVDL
GTY
GTY
Q1 26
$57.8M
Q4 25
$60.5M
Q3 25
$77.5M
$55.6M
Q2 25
$68.1M
$53.3M
Q1 25
$52.5M
$52.3M
Q4 24
$50.4M
$53.0M
Q3 24
$50.0M
$51.5M
Q2 24
$41.5M
$49.9M
Net Profit
AVDL
AVDL
GTY
GTY
Q1 26
$26.6M
Q4 25
$27.0M
Q3 25
$20.0K
$23.3M
Q2 25
$9.7M
$14.0M
Q1 25
$-4.9M
$14.8M
Q4 24
$-5.0M
$22.3M
Q3 24
$-2.6M
$15.3M
Q2 24
$-13.8M
$16.7M
Gross Margin
AVDL
AVDL
GTY
GTY
Q1 26
Q4 25
Q3 25
Q2 25
90.7%
Q1 25
89.4%
Q4 24
90.5%
Q3 24
87.7%
Q2 24
93.3%
Operating Margin
AVDL
AVDL
GTY
GTY
Q1 26
66.1%
Q4 25
67.3%
Q3 25
2.5%
62.5%
Q2 25
13.0%
46.7%
Q1 25
-5.7%
50.5%
Q4 24
-6.5%
61.6%
Q3 24
-0.7%
48.9%
Q2 24
-30.7%
52.5%
Net Margin
AVDL
AVDL
GTY
GTY
Q1 26
46.0%
Q4 25
44.7%
Q3 25
0.0%
42.0%
Q2 25
14.2%
26.3%
Q1 25
-9.4%
28.3%
Q4 24
-10.0%
42.1%
Q3 24
-5.2%
29.8%
Q2 24
-33.3%
33.5%
EPS (diluted)
AVDL
AVDL
GTY
GTY
Q1 26
$0.43
Q4 25
$0.46
Q3 25
$0.00
$0.40
Q2 25
$0.10
$0.24
Q1 25
$-0.05
$0.25
Q4 24
$-0.04
$0.38
Q3 24
$-0.03
$0.27
Q2 24
$-0.14
$0.30

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AVDL
AVDL
GTY
GTY
Cash + ST InvestmentsLiquidity on hand
$91.6M
$3.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$98.2M
Total Assets
$199.4M
$2.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AVDL
AVDL
GTY
GTY
Q1 26
$3.7M
Q4 25
$8.4M
Q3 25
$91.6M
$5.2M
Q2 25
$81.5M
$7.5M
Q1 25
$66.5M
$6.3M
Q4 24
$73.8M
$9.5M
Q3 24
$65.8M
$4.0M
Q2 24
$71.4M
$4.7M
Total Debt
AVDL
AVDL
GTY
GTY
Q1 26
Q4 25
$995.0M
Q3 25
$934.6M
Q2 25
$919.2M
Q1 25
$901.4M
Q4 24
$904.3M
Q3 24
$833.9M
Q2 24
$838.4M
Stockholders' Equity
AVDL
AVDL
GTY
GTY
Q1 26
Q4 25
$1.1B
Q3 25
$98.2M
$1.0B
Q2 25
$90.7M
$982.4M
Q1 25
$74.1M
$961.1M
Q4 24
$73.8M
$962.1M
Q3 24
$74.7M
$963.4M
Q2 24
$70.3M
$951.0M
Total Assets
AVDL
AVDL
GTY
GTY
Q1 26
$2.2B
Q4 25
$2.2B
Q3 25
$199.4M
$2.1B
Q2 25
$187.2M
$2.0B
Q1 25
$167.9M
$2.0B
Q4 24
$164.2M
$2.0B
Q3 24
$158.3M
$1.9B
Q2 24
$157.5M
$1.9B
Debt / Equity
AVDL
AVDL
GTY
GTY
Q1 26
Q4 25
0.93×
Q3 25
0.92×
Q2 25
0.94×
Q1 25
0.94×
Q4 24
0.94×
Q3 24
0.87×
Q2 24
0.88×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AVDL
AVDL
GTY
GTY
Operating Cash FlowLast quarter
$22.2M
Free Cash FlowOCF − Capex
$22.2M
FCF MarginFCF / Revenue
28.7%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
1110.25×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AVDL
AVDL
GTY
GTY
Q1 26
Q4 25
$127.4M
Q3 25
$22.2M
$30.5M
Q2 25
$12.7M
$34.7M
Q1 25
$-8.2M
$28.7M
Q4 24
$7.9M
$130.5M
Q3 24
$-6.9M
$34.6M
Q2 24
$-18.2M
$29.7M
Free Cash Flow
AVDL
AVDL
GTY
GTY
Q1 26
Q4 25
$127.0M
Q3 25
$22.2M
$30.4M
Q2 25
$34.6M
Q1 25
$28.6M
Q4 24
$129.6M
Q3 24
$34.4M
Q2 24
$29.6M
FCF Margin
AVDL
AVDL
GTY
GTY
Q1 26
Q4 25
209.8%
Q3 25
28.7%
54.7%
Q2 25
64.9%
Q1 25
54.7%
Q4 24
244.5%
Q3 24
66.9%
Q2 24
59.2%
Capex Intensity
AVDL
AVDL
GTY
GTY
Q1 26
Q4 25
0.7%
Q3 25
0.0%
0.2%
Q2 25
0.3%
Q1 25
0.1%
Q4 24
1.7%
Q3 24
0.0%
0.4%
Q2 24
0.3%
Cash Conversion
AVDL
AVDL
GTY
GTY
Q1 26
Q4 25
4.71×
Q3 25
1110.25×
1.31×
Q2 25
1.31×
2.48×
Q1 25
1.94×
Q4 24
5.85×
Q3 24
2.26×
Q2 24
1.78×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons